Onwards to Phase 3

Onwards to Phase 3

After much anticipation, this week will kick off phase 3 of the testnet. This is far ahead of the original schedule, and will mark the final testnet release before the mainnet launch.

Some Highlights to Date

Over the past few months the community has already witnessed two successful phases of Solstice. This included the early access to the exchange and then eventually the release of the trading competition.

In this time, a number of markets were added to display the capabilities of Injective that far surpass any other DEX in the market today. Some of these markets include:

Not only were contributors able to test new markets but also the underlying infrastructure of the product itself. They continued to optimize this in order to offer an unparalleled trading experience for everyone.

What to Expect from Phase 3?

Phase 3 will include the introduction of brand new Injective features and incentive mechanisms. This will help highlight some of the major avenues that will attract both additional liquidity to the Injective network and enable users to gain a firsthand look into some of the core functionalities of the INJ token itself.

This phase is expected to be by far the most exciting and eventful testnet phase. The end of phase 3 will culminate in the mainnet release. This means that phase 3 will actually refer to a number of new innovations that have been in the works for many months now.

Stay tuned for comprehensive details on how you can participate in phase 3 tomorrow.

About Injective

Injective is a custom interoperable layer one protocol for building powerful exchange, DeFi, derivatives & Web3 applications. Injective was created using the Cosmos SDK and is able to achieve instant transaction finality while sustaining lightning fast speeds. INJ is the native deflationary scarce asset that powers the Injective Protocol and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by Pantera Capital.

Website | Telegram | Discord | Blog | Twitter | Learn | Youtube | Facebook | LinkedIn | Reddit | Instagram | Weibo | Orbit Newsletter